PARIS (AFP) - French anti-doping supremo Pierre Bordry on Monday expressed his concerns over plans by the World Anti-Doping Agency (WADA) to change rules that could make it easier for athletes to use corticosteroids.

WADA has recently outlined proposals to change rules regarding Therapeutic Use Exemptions (TUE), which allow athletes to use certain medication if suffering from illnesses or a particular condition.

Although WADA's proposals are still at the consultation phase, Bordry said after a meeting with his WADA counterpart John Fahey he was worried that the rule changes would see an increase in athletes injecting corticostroids.

"We're worried in particular about the use of corticosteroids by injection," said Bordry, the president of France's national anti-doping body (AFLD).

Currently, athletes can apply to national federations, or WADA, for a TUE, of which two types exist - abbreviated and standard.

WADA's new proposals would see the disappearance of abbreviated TUE's (ATUE), meaning that athletes, as of 2009, could effectively use corticosteroids without being in possession of any TUE.

ATUE's cover the use of glucocorticosteroids - powerful anti-inflammatory agents which can be used to treat chronic inflammatory conditions - and beta-2 agonists, such as the asthma drug salbutamol.

While using glucocorticosteroids topically, such as skin creams and eye drops, has been permitted since July 1, 2007 and do not require an ATUE athletes need an ATUE to inject corticosteroids.

Injecting in sport is a sensitive issue in France - one of the first countries in Europe to introduce strict anti-doping laws - and Bordry, following a meeting with Fahey in Lyon, added: "I've told Mister Fahey of our concerns, and he has taken them on board.

"But whatever happens, the proposals to revise the rules will still be put to the various anti-doping bodies. We will continue our discussions."